Certified by Founder Lodge
PreciseDx
United States - New York, NY
START UP
1 Disclosed Funding Rounds $20,700,000
0 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
PreciseDx® is innovating oncology diagnostics, leveraging Artificial Intelligence (AI) for revolutionary, morphology-driven, disease analysis. Combining AI with our patented Morphology Featur
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| August, 22 ,2024 | Series B | $20,700,000 | |
| June, 24 ,2025 | Unknown | $11,000,000 |
Eventide Asset Management
Labcorp
Quest Diagnostics
Xsensio
CND Life Sciences
NYBC Ventures
PinkDx, Inc.
Sizable Energy | $8,000,000 | (Oct 24, 2025)
Sumble | $38,500,000 | (Oct 24, 2025)
Syntracts | $5,300,000 | (Oct 24, 2025)
Cybrid | $10,000,000 | (Oct 24, 2025)
Elevara Medicines | $70,000,000 | (Oct 24, 2025)
